NDC 73556-168

TAVNEOS

Avacopan

TAVNEOS is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Chemocentryx, Inc.. The primary component is Avacopan.

• Product ID: 73556-168_16ccb471-a392-4495-97ff-539a1ef1dce2
• NDC: 73556-168
• Product Type: Human Prescription Drug
• Proprietary Name: TAVNEOS
• Generic Name: Avacopan
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2021-10-18
• Marketing Category: NDA /
• Application Number: NDA214487
• Labeler Name: ChemoCentryx, Inc.
• Substance Name: AVACOPAN
• Active Ingredient Strength: 10 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 73556-168-01

1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01) > 180 CAPSULE in 1 BOTTLE, PLASTIC

• Marketing Start Date: 2021-10-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details